Semaglutide Oral
Metabolic & Weight ManagementOral formulation of semaglutide using SNAC absorption enhancer, first oral GLP-1 approved.
Key Benefits
- ✓First oral GLP-1 agonist
- ✓Improves glucose control
- ✓Modest weight loss
- ✓No injections
- ✓Daily pill convenience
Dosing Information
Detailed Protocol
Taken orally once daily on empty stomach with small amount of water (4 oz). Must wait 30 minutes before eating or drinking. Strict dosing requirements for absorption.
About Semaglutide Oral
Semaglutide oral (Rybelsus) is the same semaglutide peptide as injectable forms but formulated with SNAC (sodium N-(8-[2-hydroxybenzoyl] amino) caprylate) to enhance absorption. First oral GLP-1 agonist approved by FDA. Lower bioavailability than injectable but offers oral convenience.
Research Notes
FDA-approved in 2019 for type 2 diabetes. PIONEER trials showed efficacy with oral formulation. Bioavailability only 0.4-1% but sufficient for therapeutic effect. Strict dosing requirements.
Potential Side Effects
- •Nausea
- •Abdominal pain
- •Diarrhea
- •Vomiting
- •Less weight loss than injectable
Always consult with a healthcare professional before starting any peptide therapy.